A new multinational clinical trial marks a significant step in developing transformative gene therapies for rare inherited disorders.
A new multinational clinical trial marks a significant step in developing transformative gene therapies for rare inherited disorders.
Ionis Pharmaceuticals is driving progress in antisense technology, demonstrating meaningful advances in genetic disease treatment
Moderna pushes the boundaries of mRNA therapy into rare genetic diseases, aiming for transformative treatments.
Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Australian-led clinical trials are advancing the future of diabetes care with oral insulin innovations.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
New device approval and robust oncology funding highlight ongoing biopharma momentum in cancer therapies.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
Next-generation gene editing powers new hope for hard-to-treat solid tumors in early human trials.
A landmark Australian trial will test olfactory cell transplantation combined with intensive rehab to restore function in chronic …
Already a subscriber? Log in